POST Online Media Lite Edition



 

Bruker appoints Robert Rosenthal to board

Staff writer |
Billerica, Mass., USA - November 17, 2015, Billerica, Mass., USA - Bruker Corporation, a provider of instruments and solutions for molecular and materials research, announced that it has appointed Robert Rosenthal to its board of directors.

Article continues below






Dr. Rosenthal currently serves as Chief Executive Officer and as a director for Taconic Biosciences, Inc., a privately-held provider of research models for the pharmaceutical and biotech industry, a position he has held since joining Taconic Biosciences in June 2014.

Prior to joining Taconic Biosciences, Dr. Rosenthal held a variety of senior management positions with companies involved in the development of diagnostics, therapeutics, medical devices, and life sciences tools, most recently as Chairman and Chief Executive Officer of Intelligent Medical Implants, AG, a medical technology company.

He has also served as President and Chief Executive Officer of Magellan Biosciences, Inc., a provider of clinical diagnostics and life sciences research tools. Dr. Rosenthal also serves as a director of Safeguard Scientifics, Inc., a publicly-traded provider of capital for early- and growth-stage companies, and for Galvanic Applied Sciences, Inc., a privately held Canadian company.

LATEST 5 MOVES FROM Massachusetts 


What to read next

Bruker: Bernd Gewiese and Werner Maas co-presidents of Bruker BioSpin Division
Milestone Aviation names Daniel Rosenthal president and CEO
hybris appoints SVP of sales, Americas